Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Roberta Ferreira
Advertisement
Director, North and South America, Clinical TrialSystem and Auditing QA, RDQ, Bristol Myers Squibb
Articles by Roberta Ferreira
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
2
Bringing Clinical Trials Into the Digital Era with eConsent
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
